“…Some limitations need to be acknowledged: first, healthy subjects were enrolled, and the peripheral circulation was tested in this experimental model. Although abnormalities in FMD have been shown in many conditions [28][29][30][31][32][33], like for any model, the translation of the present data to the clinical setting (patients with coronary artery disease, coronary or cerebral circulation) needs to be further investigated. Similarly, the data from isolated endothelial cells should not be automatically transferred to the clinical/ human in vivo setting, and additional mechanisms could explain our observations, even though we previously showed human in vivo ALDH-2 inhibition in response to GTN [34].…”